Dr. Eric Topol

It's also going to give an advantage to other countries around the world who are not going through this.

Yeah, so this is really the reason why we're moving into this hyper-accelerated phase of discovery and transforming medicine.

For one, we're seeing the discovery of new drugs.

In fact, a drug for a very severe lung condition that we don't have a good treatment for, idiopathic pulmonary fibrosis.

This is the first AI-discovered drug that is now

passed a phase two trial, so it's pretty far along and it looks great, discovered by AI.

So that's one part of the story.

Another is that the way we practice in medicine is getting so much more efficient by just having our conversations made into synthetic notes that are far better than the notes that are in our...

This is freeing up two, three, four hours a day for clinicians, and it just keeps getting better.

And it's not just a note.

That whole AI product is being used to order the tests and do the coding and for future appointments, prescriptions, preauthorizations.

I mean, all the things that occupy physicians.

Exactly.

So that restoration of the patient-doctor relationship is starting to really take hold, which is great.

And of course, what I think is the biggest, most exciting frontier is using AI to extend our health span.

And this is something I think that up until now, we didn't realize how we have this truly remarkable opportunity.

And that's why I put so much work into this for agers thing, just because we're going to do this.

Yeah, I'm so glad you mentioned that.

And actually, you articulated it quite well.

The story here is that there was the largest ever randomized trial of AI in medicine.